× Medicines Discovery Catapult

We’re providing updates on the COVID-19 situation for the UK drug discovery community. Our aim is to help the community during this challenging time and also highlight important work and resources.


CORD-19 – COVID-19 Open Research Dataset
The Semantic Scholar team at the Allen Institute for AI has partnered with leading research groups to provide CORD-19, a free resource of more than 130,000 scholarly articles about the novel coronavirus for use by the global research community.
Find out more >


COVID-19 Protein Portal
Accelerate your COVID-19 research by sourcing key reagents from leading UK protein production laboratories.
Find out more >


COVID-19 Collaboration Centre
This free COVID-19 Collaboration Center (CCC) was built by software engineers and scientists at Scientist.com. Our goal is to empower researchers, protect healthcare workers and help cure this disease.
Find out more >


NIHR’s response to COVID-19
On behalf of the Department of Health and Social Care, the NIHR is playing a critical role in terms of funding, enabling and delivering research into COVID-19.
Find out more >


COVID-19 preclinical drug development database
The Academy of Medical Sciences is maintaining a database of preclinical drugs in development.
Find out more >


Samples for COVID-19 research
The UKCRC Tissue Directory and Coordination Centre (TDCC) is coordinating efforts to help find human sample resources that are available to support research into COVID-19.
Find out more >


COVID-19 Open Research Dataset Challenge (CORD-19)
In response to the COVID-19 pandemic, the White House and a coalition of leading research groups have prepared the COVID-19 Open Research Dataset (CORD-19). CORD-19 is a resource of over 45,000 scholarly articles, including over 33,000 with full text, about COVID-19, SARS-CoV-2, and related coronaviruses. This freely available dataset is provided to the global research community to apply recent advances in natural language processing and other AI techniques to generate new insights in support of the ongoing fight against this infectious disease.
Find out more >


The COVID-19 HPC Consortium
The COVID-19 HPC Consortium encompasses computing capabilities from some of the most powerful and advanced computers in the world. We hope to empower researchers around the world to accelerate understanding of the COVID-19 virus and the development of treatments and vaccines to help address infections. Consortium members manage a range of computing capabilities that span from small clusters to some of the very largest supercomputers in the world.

Resources available for COVID-19 HPC Consortium request:

  • U.S. Department of Energy (DOE) Advanced Scientific Computing Research (ASCR)
  • U.S. DOE National Nuclear Security Administration (NNSA)
  • U.S. National Science Foundation (NSF)
  • NASA High-End Computing Capability
  • Google
  • Amazon Web Services
  • Microsoft
  • MIT/Massachusetts Green HPC Center (MGHPCC)
  • Rensselaer Polytechnic Institute
  • IBM Research

Find out more >


Clinical Practice Research Datalink (CPRD) is expediting the processing of protocols related to COVID-19 research

Find out more >


The Health Research Authority (HRA) are publishing details about all approved COVID-19 research studies online within 3 days of approval

Find out more >


Managing clinical trials during Coronavirus (COVID-19)

Find out more >